Literature DB >> 26436748

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness.

Eric C T Geijteman1, Henning Tiemeier2, Teun van Gelder3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26436748     DOI： 10.1001/jamainternmed.2015.3997

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Drug prescribing during the last year of life in very old people with diabetes.

Authors:  Shota Hamada; Martin C Gulliford
Journal:  Age Ageing       Date:  2017-01-15       Impact factor: 10.668

2.  Sex-Differences in Discontinuation of Statin Treatment in Cancer Patients the Year before Death.

Authors:  Gabriella Frisk; Helena Bergström; Maria Helde Frankling; Linda Björkhem-Bergman
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-16

3.  Discussion around statin discontinuation in older adults and patients with wasting diseases.

Authors:  Maciej Banach; Maria-Corina Serban
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-02-29       Impact factor: 12.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.